As­traZeneca los­es ap­peals court fight over IRA drug price ne­go­ti­a­tions

As­traZeneca lost its chal­lenge to Medicare drug price ne­go­ti­a­tions in the first ap­peals court rul­ing on the mer­its of the Biden-era pro­gram.

The

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA